Mobile-health Network Solutions (MNDR) 주식 분석

회사 개요

Mobile-health Network Solutions, ticker symbol MNDR, operates primarily as an investment holding company focused on delivering telehealth solutions within the Singapore market. The firm functions within the broader Healthcare sector, specifically categorized under the Health Information Services industry, which involves the management and processing of medical data to support clinical operations. This entity employs a workforce of 73 individuals and maintains a market capitalization of $3.01M, reflecting its status as a micro-cap entity within the specialized medical technology landscape. With a trailing twelve-month revenue of $7.32M, the company's financial scale suggests it occupies a niche position, likely serving a specific segment of the regional telemedicine market rather than competing in the global mass market for such services.

재무 건전성

The company reported revenue of $7.32M over the trailing twelve months, yet recorded a net income loss of $-2,586,343, highlighting a significant operational deficit where costs substantially exceed gross earnings. EBITDA stands at $-2,503,371, indicating that even before interest, taxes, depreciation, and amortization, the core business operations are generating negative cash value from its activities. The absence of reported free cash flow figures suggests that cash generation is either negligible or entirely consumed by ongoing operational expenditures and capital requirements. Gross margin is recorded at 19.7%, which indicates that the company retains less than one-fifth of its revenue after direct costs, pointing to a cost structure where production or service delivery expenses are high relative to sales. Operating margin is -22.2% and profit margin is -35.3%, further demonstrating that administrative and overhead costs, combined with the low gross margin, result in substantial losses on every dollar of revenue generated. The company holds $3.48M in cash against $115,463 in debt, resulting in a debt-to-equity ratio of 1.39, which presents a complex balance sheet profile where significant cash reserves coexist with high leverage relative to equity. Despite holding a current ratio of 4.22, which indicates strong short-term liquidity and the ability to cover current liabilities more than four times over, the firm faces the challenge of deploying capital to reverse negative trends. Return on Equity is -47.6% and Return on Assets is -23.5%, metrics that reveal that management has not yet achieved positive returns on shareholder capital or the asset base, signaling a period of investment or restructuring rather than profitability.

밸류에이션 평가

Trailing P/E and forward P/E ratios are both listed as N/A due to the company's consistent losses, meaning traditional earnings-based valuation multiples cannot be applied to assess future earnings trajectory or market expectations of profitability turnaround. The price-to-book ratio is 0.35, indicating that the market values the company at significantly less than its net book value, which often occurs in distressed firms or those with intangible-heavy balance sheets where market perception diverges from accounting values. Price-to-sales ratio stands at 0.41 and EV/EBITDA is 0.20, suggesting that alternative valuation metrics price the stock at a fraction of its sales and earnings power, reflecting extreme market skepticism regarding near-term cash flow generation. The 52-week high is $9.01 and the 52-week low is $0.76, placing the stock's trading range within a wide band that suggests high volatility and sensitivity to investor sentiment regarding its turnaround potential. Beta is listed as N/A, preventing a direct comparison of the stock's price volatility relative to the broader market index, though the wide spread between high and low implies inherent instability in the share price.

Growth & Income

Revenue growth year-over-year is -7.7%, while earnings growth is N/A due to the lack of positive earnings history, indicating that the company is currently contracting in terms of top-line sales without a path to profitable scaling. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which implies that all available cash and retained earnings are theoretically available for reinvestment rather than distribution to shareholders. This reinvestment strategy is typical for loss-making entities attempting to fund operations or develop new capabilities to achieve future profitability. Overall, the growth and income profile characterizes Mobile-health Network Solutions as a non-dividend payer in a contractionary revenue phase, relying entirely on operational improvements to transition from a negative earnings and growth state to a sustainable positive trajectory.